Michael Chez
Neurology with Special Qualifications in Child Neurology · Sacramento, CANPI 1003998618
Payments from drug & device makers
Across 990 payments — averaging $459.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$119K
- Eisai Inc.$117K
- Neurelis, Inc.$42K
- GW Research Limited$37K
- Greenwich Biosciences, Inc.$23K
- SK Life Science, Inc.$18K
- plus $99K from 23 others
Across 1 payment — averaging $420.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB, Inc.$420
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 435 | $119,052 |
| Eisai Inc. | 90 | $116,647 |
| Neurelis, Inc. | 52 | $42,270 |
| GW Research Limited | 6 | $36,575 |
| Greenwich Biosciences, Inc. | 66 | $22,795 |
| SK Life Science, Inc. | 47 | $18,097 |
| Aquestive Therapeutics, Inc. | 49 | $17,279 |
| Catalyst Pharmaceuticals, Inc. | 25 | $17,014 |
| Immedica Pharma US, Inc. | 39 | $16,868 |
| Zogenix Inc. | 18 | $12,692 |
| UCB SA | 4 | $9,090 |
| Jazz Pharmaceuticals Inc. | 50 | $8,140 |
| Mallinckrodt Hospital Products Inc. | 4 | $5,754 |
| Eisai CO., LTD. | 2 | $5,180 |
| Otter Pharmaceuticals, LLC | 1 | $1,674 |
| Biocodex, Inc. | 8 | $1,642 |
| Supernus Pharmaceuticals, Inc. | 14 | $1,588 |
| Sunovion Pharmaceuticals Inc. | 51 | $1,446 |
| Monteris Medical Corporation | 1 | $159 |
| Livanova USA, Inc. | 3 | $139 |
| Abbott | 1 | $124 |
| Mallinckrodt Enterprises LLC | 10 | $115 |
| Neuropace, Inc. | 2 | $82 |
| Medtronic | 1 | $80 |
| Tris Pharma Inc | 2 | $63 |
| Upsher-smith Laboratories LLC | 2 | $60 |
| Ceribell, Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 5 | $24 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
How this compares
$454,695 in reported general payments places this provider in the 90th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Other neurology with special qualifications in child neurology in Sacramento
- Temitayo ChidiSacramento$317K
- Shailesh AsaikarSacramento$32K
- Sabine MuellerSan Francisco$17.5M
- Joseph SullivanSan Francisco$1.7M
- Rajsekar RajaramanLos Angeles$1.5M
- Jonathan SantoroPalo Alto$1.5M
- Michelle MonjePalo Alto$1.3M
- Jay DesaiLos Angeles$1.2M
- Richard HaasSan Diego$1.2M
- Leigh Maria Ramos PlattLos Angeles$981K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.